Investigation of poorer bladder cancer survival in women in NSW, Australia: A data linkage study

BJU International

Volumn 113, Issue 3, 2014, Pages 437-448

  Tracey, Elizabeth ^a   Watt, Hunter ^b   Currow, David ^c   Young, Jane ^a   Armstrong, Bruce ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c CANCER INSTITUTE NSW   (Australia)

Author keywords

bladder cancer; cancer registry; cystitis; distance; surgery; survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BLADDER CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; CYSTECTOMY; CYSTITIS; DISTANT METASTASIS; FEMALE; HAZARD RATIO; HEALTH CARE FACILITY; HEMATURIA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PRIVATE HOSPITAL; PROGNOSIS; PUBLIC HOSPITAL; RISK FACTOR; RURAL AREA; SEX DIFFERENCE; SMOKING; SURVIVAL TIME; THERAPY DELAY; VERY ELDERLY;

BLADDER CANCER; CANCER REGISTRY; CYSTITIS; DISTANCE; SURGERY; SURVIVAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CYSTECTOMY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PROGNOSIS; RESIDENCE CHARACTERISTICS; SEX DISTRIBUTION; SEX FACTORS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84896708115     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12496     Document Type: Article

References (51)

1. Tracey E, Chen S, Baker D, Bishop J, Jelfs P,. Cancer in New South Wales: Incidence and Mortality 2004. Sydney: Cancer Institute NSW, 2006
2. Ries L, Young J, Keel G, et al. SEER Survival Monograph: Cancer Survival among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. 2007 (07-6215)
3. Shah A, Rachet B, Mitry E, Cooper N, Brown CM, Coleman MP,. Survival from bladder cancer in England and Wales up to 2001. Br J Cancer 2008; 99 (Suppl. 1): S86-89
4. Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P,. The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. Eur J Cancer 1998; 34 (14 Spec No): 2271-2278 (Pubitemid 29036897)
5. Coleman MP, Babb P, Damiecki P, Cancer GPC,. Survival Trends in England and Wales 1971-1995: Deprivation and NHS Region. London: The Stationery Office, 1999
6. Tracey E, Roder D, Luke C, Bishop J,. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men? BJU Int 2009; 104: 498-504
7. National Centre for Classification in Health. The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM): 2010
8. Health Mo ed. Cancer Registry-Notifying Cancer Cases to the NSW Central Cancer Registry. NSW, 12 March 2009
9. Ministry of Health. Data Collections- Disclosure of Unit Record Data Held for Research Or Management of Health Services. Sydney, NSW: Ministry of Health, 2006
10. CHEREL. Centre for Health Record Linkage MLK Quality Assurance. NSW, 2011
11. Tracey E, Barraclough H, Chen W, et al. Survival from Cancer in NSW: 1980 to 2003. Sydney: Cancer Institute NSW and the New South Wales Department of Health, 2007
12. Fritz AG,. International Classification of Diseases for Oncology: ICD-O. Geneva: World Health Organization, 2000
13. Pink B,. Socio-Economic Indexes for Areas (SEIFA)-Technical Paper. Canberra, ACT: Commonwealth of Australia, 2006
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383 (Pubitemid 17055592)
15. Gomez S, Glaser S, McClure L, et al. The California Neighborhoods Data System: a new resource for examining the impact of neighborhood characteristics on cancer incidence and outcomes in populations. Cancer Causes Control 2011; 22: 631-647
16. Academic Technology Services Statistical Consulting Group. Introduction to SAS.UCLA. 2007. Available at: http://www.ats.ucla.edu/stat/sas/notes. Accessed 23 August 2013
17. Parkin DM,. The global burden of urinary bladder cancer. Scand J Urol Nephrol 2008; 42 (s218): 12-20
18. Mungan NA, Aben KKH, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000; 55: 876-880 (Pubitemid 30330791)
19. Division PH,. The Health of the People of New South Wales-Report of the Chief Health Officer. Sydney: NSW Department of Health, Available at: 2010. www.health.nsw.gov.au/publichealth/chorep/. Accessed 23 August 2013
20. The Australian Bureau of Statistics. Tobacco Smoking in Australia: A Snapshot, 2004-05. Canberra: The Australian Bureau of Statistics, 2006
21. National Health Survey: Users' Guide, 2004-05-Electronic Publication, Australia Canberra, 2006
22. Lain SJ, Hadfield RM, Raynes-Greenow CH, et al. Quality of Data in Perinatal Population Health Databases. 2011
23. Brooks JD,. Anatomy of the Lower Urinary Tract and Male Genitalia. Campbell-Walsh Urology, 9th edn. Philadelphia, PA: Saunders Elsevier, 2007
24. Maralani S, Wood DP, Grignon D, Banerjee M, Sakr W, Pontes JE,. Incidence of urethral involvement in female bladder cancer: an anatomic pathologic study. Urology 1997; 50: 537-541 (Pubitemid 27433212)
25. Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA,. Gender differences in stage distribution of bladder cancer. Urology 2000; 55: 368-371 (Pubitemid 30110586)
26. Metts JF,. Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 2001; 64: 1199-1206
27. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ,. Epidemiology of interstitial cystitis: a population based study. J Urol 1999; 161: 549-552
28. Henning A, Wehrberger M, Madersbacher S, et al. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 2013; 112: 68-73
29. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF,. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 1984; 119: 510-515 (Pubitemid 14134659)
30. Kjaer SK, Knudsen JB, Sorensen BL, Moller Jensen O,. The Copenhagen case-control study of bladder cancer. V. Review of the role of urinary-tract infection. Acta Oncol 1989; 28: 631-636 (Pubitemid 20012782)
31. Davis CP, Cohen MS, Gruber MB, Anderson MD, Warren MM,. Urothelial hyperplasia and neoplasia: a response to chronic urinary tract infections in rats. J Urol 1984; 132: 1025-1031 (Pubitemid 14023534)
32. Slobodov G, Feloney M, Gran C, et al. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 2004; 171: 1554-1558 (Pubitemid 38365417)
33. Shie JH, Kuo HC,. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome. BJU Int 2011; 108 (2b): E136-141
34. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML,. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol 2001; 32: 690-697 (Pubitemid 32726893)
35. Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994; 174: 243-248
36. Andrews N, Jones A, Helliwell T, Kinsella A,. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 1997; 75: 1474-1480 (Pubitemid 27196868)
37. Hollenbeck BK, Dunn RL, Ye Z, et al. Delays in diagnosis and bladder cancer mortality. Cancer 2010; 116: 5235-5242
38. Mahmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG,. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol 2006; 175: 78-83; discussion (Pubitemid 41797090)
39. Sanchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB,. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 2003; 169: 110-115; discussion 115 (Pubitemid 35461564)
40. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS,. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 2009; 115: 988-996
41. Baldwin LM, Cai Y, Larson EH, et al. Access to cancer services for rural colorectal cancer patients. J Rural Health 2008; 24: 390-399
42. Baldwin LM, Taplin SH, Friedman H, Moe R,. Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma? Cancer 2004; 100: 701-709 (Pubitemid 38176846)
43. Schroen AT, Brenin DR, Kelly MD, Knaus WA, Slingluff CL Jr,. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 2005; 23: 7074-7080
44. Tropman SE, Ricketts TC, Paskett E, Hatzell TA, Cooper MR, Aldrich T,. Rural breast cancer treatment: evidence from the Reaching Communities for Cancer Care (REACH) project. Breast Cancer Res Treat 1999; 56: 59-66 (Pubitemid 29435815)
45. Gore JL, Litwin MS, Lai J, et al. Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 2010; 102: 802-811
46. Needham DM, Scales DC, Laupacis A, Pronovost PJ,. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005; 20: 12-19 (Pubitemid 40602219)
47. Prout GR, Wesley MN, Yancik R, Ries LAG, Havlik RJ, Edwards BK,. Age and comorbidity impact surgical therapy in older bladder carcinoma patients. Cancer 2005; 104: 1638-1647 (Pubitemid 41437427)
48. Yafi FA, Aprikian AG, Fradet Y, et al. Contemporary outcomes of radical cystectomy in 2287 patients with transitional cell carcinoma of the bladder: a Canadian multi-institutional experience. J Urol 2009; 181: 377
49. Mayer WJ, McWhorter WP,. Black/white differences in non-treatment of bladder cancer patients and implications for survival. Am J Public Health 1989; 79: 772-775 (Pubitemid 19142921)
50. Prout GR Jr, Wesley MN, Greenberg RS, et al. Bladder cancer: race differences in extent of disease at diagnosis. Cancer 2000; 89: 1349-1358
51. Brookfield KF, Cheung MC, Gomez C, et al. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer 2009; 115: 4196-4209